
BLI
Healthcare · Biotechnology & Medical Research · $86.6M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2023
EPS trend, 90 days to now · +9.7% over 90 days · 30-day revisions 3 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 8, 2023 | Before the open | -0.28 | -0.31 | -10.7% |
| Feb 23, 2023 | After the close | -0.27 | -0.41 | -51.9% |
| Nov 8, 2022 | After the close | -0.30 | -0.32 | -6.7% |
| Aug 9, 2022 | After the close | -0.32 | -0.38 | -18.8% |
| May 9, 2022 | After the close | -0.31 | -0.32 | -3.2% |
| Feb 24, 2022 | Before the open | -0.28 | -0.26 | +7.1% |
| Nov 4, 2021 | Before the open | -0.24 | -0.30 | -25.0% |
| Aug 11, 2021 | Before the open | -0.24 | -0.27 | -12.5% |
| May 11, 2021 | Before the open | -0.24 | -0.24 | 0.0% |
| Feb 25, 2021 | After the close | -0.20 | -0.19 | +5.0% |
| Nov 12, 2020 | After the close | -0.20 | -0.16 | +20.0% |
| Jul 17, 2020 | After the close | -0.19 | -4.25 | -2136.8% |
| May 1, 2020 | Time not confirmed | — |
Berkeley Lights, Inc., a cell biology company, operates in enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products in North America, the Asia Pacific, and Europe. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software.…
| -0.15 |
| — |